Treace Medical Concepts, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Treace Medical Concepts, Inc. (TMCI) had Deferred Tax Assets, Operating Loss Carryforwards of $38.09 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-27
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $38.09M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $28.19M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $22.95M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $15.98M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $38.09M 10-K · filed 2026-02-27 |
| 2024-12-31 | $28.19M 10-K · filed 2026-02-27 |
| 2023-12-31 | $22.95M 10-K · filed 2025-02-27 |
| 2022-12-31 | $15.98M 10-K · filed 2024-02-27 |
| 2021-12-31 | $8.26M 10-K · filed 2023-03-08 |
| 2020-12-31 | $3.70M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |